TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Assets | ₹43,614 Cr | ₹14,396 Cr | ₹14,505 Cr | ₹14,468 Cr | ₹12,606 Cr |
What is the latest Total Assets ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Assets |
|---|---|
| Mar2026 | ₹43,614 Cr |
| Mar2025 | ₹14,396 Cr |
| Mar2024 | ₹14,505 Cr |
| Mar2023 | ₹14,468 Cr |
| Mar2022 | ₹12,606 Cr |
How is Total Assets of TORRENT PHARMACEUTICALS Trending?
| Years | Total Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹43,614 Cr | 202.97 | |
| Mar2025 | ₹14,396 Cr | -0.76 | |
| Mar2024 | ₹14,505 Cr | 0.26 | |
| Mar2023 | ₹14,468 Cr | 14.77 | |
| Mar2022 | ₹12,606 Cr | - | |
Compare Total Assets of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹191,341.2 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| MANKIND PHARMA | ₹101,638.0 Cr | -5.1% | -3.1% | -2.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3.1% |
4.3% |
38.5% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses